PBE Invesco Dynamic Biotech & Genome ETF
Seeks to track, before fees and expenses, the Dynamic Biotech & Genome Intellidex Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.
$56.28 +0.70 (1.26%)
As of 05/20/2022 15:59:45 EST IEX book CBOE book
ETF Information
Sponsor: Invesco
Category1: US Equity
Category2: Single industry
Category3: Biotechnology
Morningstar category: Health
Leverage factor: 1.00
Inception date: 06/23/2005
Index tracking method: Passive replication
Current yield: 0.00%
Historical average yield: 0.22%
Market cap: $205,646,000
Average volume: 13,072
Fees: 0.5900%
Index Information
Dynamic Biotech & Genome Intellidex Index
Index symbol: DZO
Provider: ICE (NYSE)
Total return index symbol: DZOTR
Index weighting: Other
Index inception date: 02/28/2003
Backtesting data exists: No
Index methdology guide: Read PDF
Number of holdings: 30
Strategy: Multi-factor investing
Factors used to select securities: